JP2010523599A5 - - Google Patents

Download PDF

Info

Publication number
JP2010523599A5
JP2010523599A5 JP2010502352A JP2010502352A JP2010523599A5 JP 2010523599 A5 JP2010523599 A5 JP 2010523599A5 JP 2010502352 A JP2010502352 A JP 2010502352A JP 2010502352 A JP2010502352 A JP 2010502352A JP 2010523599 A5 JP2010523599 A5 JP 2010523599A5
Authority
JP
Japan
Prior art keywords
alkyl
aryl
group
heteroaryl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010502352A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010523599A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/059599 external-priority patent/WO2008124703A2/en
Publication of JP2010523599A publication Critical patent/JP2010523599A/ja
Publication of JP2010523599A5 publication Critical patent/JP2010523599A5/ja
Pending legal-status Critical Current

Links

JP2010502352A 2007-04-05 2008-04-07 クリックケミストリーを使用した炭酸脱水酵素−ixのための分子イメージングプローブの開発 Pending JP2010523599A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92206507P 2007-04-05 2007-04-05
PCT/US2008/059599 WO2008124703A2 (en) 2007-04-05 2008-04-07 Development of molecular imaging probes for carbonic anhydrase-ix using click chemistry

Publications (2)

Publication Number Publication Date
JP2010523599A JP2010523599A (ja) 2010-07-15
JP2010523599A5 true JP2010523599A5 (enExample) 2010-12-02

Family

ID=39743771

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010502352A Pending JP2010523599A (ja) 2007-04-05 2008-04-07 クリックケミストリーを使用した炭酸脱水酵素−ixのための分子イメージングプローブの開発

Country Status (7)

Country Link
US (2) US7829063B2 (enExample)
EP (2) EP2468734A1 (enExample)
JP (1) JP2010523599A (enExample)
KR (2) KR20120003499A (enExample)
CN (1) CN101679318A (enExample)
CA (1) CA2683434A1 (enExample)
WO (1) WO2008124703A2 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2703981A1 (en) * 2007-10-29 2009-05-07 Schering Corporation Heterocyclic urea and thiourea derivatives and methods of use thereof
EP2240171B1 (en) * 2008-01-09 2014-08-13 Molecular Insight Pharmaceuticals, Inc. Inhibitors of carbonic anhydrase IX
US8562945B2 (en) 2008-01-09 2013-10-22 Molecular Insight Pharmaceuticals, Inc. Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof
BRPI0923305B1 (pt) 2008-12-09 2019-01-22 Gilead Sciences Inc moduladores de receptores toll-like, seu uso e composição farmacêutica que os compreende
BR112012000210A2 (pt) 2009-06-15 2019-09-24 Molecular Insight Pharm Inc processo para a produção de heterodímeoros de ácido glutâmico.
US9914745B2 (en) 2009-08-14 2018-03-13 Indian Association For The Cultivation Of Science Morpholino-based antisense agent
WO2011047796A1 (en) * 2009-10-21 2011-04-28 Bayer Schering Pharma Aktiengesellschaft Substituted halophenoxybenzamide derivatives
US10639608B2 (en) 2010-04-08 2020-05-05 Siemens Medical Solutions Usa, Inc. System, device and method for preparing tracers and transferring materials during radiosynthesis
EP2556372A1 (en) * 2010-04-08 2013-02-13 Siemens Medical Solutions USA, Inc. Synthesis of 18f-labeled tracers in hydrous organic solvents
BR112013010333A2 (pt) * 2010-10-29 2017-07-25 Clino Ltd sonda de imageamento de tau
BR112013011830B1 (pt) * 2010-11-13 2022-03-15 Innocrin Pharmaceuticals, Inc Composto inibidor de metaloenzima, composição que compreende o dito composto, bem como uso do mesmo para tratar uma doença ou transtorno relacionado à metaloenzima
WO2012118715A2 (en) * 2011-02-28 2012-09-07 The Board Of Trustees Of Leland Stanford Junior University Non-peptidic quenched fluorescent imaging probes
CN102219753B (zh) * 2011-04-21 2012-10-31 山东大学 一种三氮唑类化合物及其制备方法与应用
CN110204478A (zh) 2011-05-09 2019-09-06 文森医学公司 碳酸酐酶靶向剂及其使用方法
JP2014156400A (ja) * 2011-05-24 2014-08-28 Astellas Pharma Inc 腫瘍の画像診断用標識誘導体
EP2800471A4 (en) 2012-01-06 2015-11-04 Molecular Insight Pharm Inc METAL COMPLEX OF POLY (CARBOXYL) AMINE CONTAINING LIGANDS HAVING AFFINITY FOR CARBON IX ANHYDRASE
EP2831264B1 (en) 2012-03-30 2019-07-10 VisEn Medical, Inc. Bacterial imaging agents and methods of using same
EP3545978B1 (en) 2013-01-14 2021-09-08 Molecular Insight Pharmaceuticals, Inc. Triazine based radiopharmaceuticals and radioimaging agents
TW201609674A (zh) 2013-11-05 2016-03-16 拜耳作物科學股份有限公司 用於控制節肢動物的新穎化合物(二)
ES2930667T3 (es) 2014-07-11 2022-12-21 Gilead Sciences Inc Moduladores de receptores de tipo Toll para el tratamiento de VIH
CN104212440B (zh) * 2014-09-03 2016-03-30 无锡艾德美特生物科技有限公司 一类喹唑啉类荧光探针及其制备和应用
JP2017526730A (ja) 2014-09-16 2017-09-14 ギリアード サイエンシーズ, インコーポレイテッド Toll様受容体モジュレーターの固体形態
TWI780423B (zh) * 2014-09-16 2022-10-11 美商基利科學股份有限公司 類鐸受體調節劑的製備方法
AU2016236239B2 (en) 2015-03-24 2020-06-25 H. Lundbeck A/S Manufacture of 4,5,6,7-tetrahydroisozaxolo[5,4-c]pyridin-3-ol
LT6401B (lt) 2015-07-28 2017-06-12 Vilniaus Universitetas Karboanhidrazės selektyvūs inhibitoriai
CN105541825A (zh) * 2015-12-28 2016-05-04 中国药科大学 三氮唑衍生物制备方法及其作为药物的用途
AU2017263630B2 (en) * 2016-05-13 2021-11-04 The Johns Hopkins University Nuclear imaging and radiotherapeutics agents targeting carbonic anhydrase IX and uses thereof
US10695450B2 (en) 2016-07-26 2020-06-30 Laboratoires Cyclopharma Synthesis of a radioactive agent composition
CN110785414A (zh) * 2017-04-20 2020-02-11 加利福尼亚大学董事会 K-Ras调节剂
CA3072854A1 (en) * 2017-08-17 2019-02-21 Glaxosmithkline Intellectual Property Development Limited Novel tetrazole compounds and their use in the treatment of tuberculosis
KR102147971B1 (ko) * 2019-11-22 2020-08-25 국방과학연구소 반응용매에 대한 혼화성 차이를 이용한 화학선택적 트리아졸의 제조방법
WO2025113696A1 (zh) * 2023-11-30 2025-06-05 赣州和美药业股份有限公司 一种化合物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562319B2 (en) * 2001-03-12 2003-05-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy
WO2004048544A2 (en) * 2002-11-26 2004-06-10 Bayer Healthcare Ca ix-specific inhibitors
US20060269942A1 (en) * 2005-04-27 2006-11-30 Kolb Hartmuth C In situ click chemistry method for screening high affinity molecular imaging probes
EP1733742A1 (en) 2005-06-17 2006-12-20 Universiteit Utrecht Holding B.V. Dendrimers multivalently substituted with active groups
WO2007018431A2 (en) 2005-08-05 2007-02-15 Syntarga B.V. Triazole-containing releasable linkers and conjugates comprising the same
US8470587B2 (en) * 2006-08-28 2013-06-25 The Trustees Of The University Of Pennsylvania 129Xe biosensors and their use
WO2008033557A2 (en) 2006-09-15 2008-03-20 Siemens Medical Solutions Usa, Inc. Click chemistry-derived cyclic peptidomimetics as integrin markers

Similar Documents

Publication Publication Date Title
JP2010523599A5 (enExample)
US11147889B2 (en) Albumin-binding PSMA inhibitors
WO2009155017A3 (en) Novel substituted azabenzoxazoles
JP2016534063A5 (enExample)
JP2023519247A (ja) Fap標的化放射性医薬品およびイメージング剤、ならびにそれらに関連する使用
JP2013544846A5 (enExample)
JP2010511632A5 (enExample)
JP2015508103A5 (enExample)
DK2864329T3 (en) 18F-LABELED PHOLATE / ANTIFOLATE ANALOGS
JP2013523896A5 (enExample)
JP2017531619A5 (enExample)
JP2015518004A5 (enExample)
JP2013534248A5 (enExample)
RU2019142507A (ru) Композиции, способы и системы для синтеза и применение визуализирующих средств
JP2008195730A5 (enExample)
WO2015191506A3 (en) Pyrrolo[2,3-c]pyridines as imaging agents for neurofibrilary tangles
JP2020507589A5 (enExample)
JP2011513298A5 (enExample)
JP2015511609A5 (enExample)
JP5500875B2 (ja) 新規化合物、該新規化合物を用いたプローブ及び該新規化合物もしくは該プローブを用いた蛍光イメージング用造影剤
JP2012506439A5 (enExample)
JP2016527202A5 (enExample)
RU2012124266A (ru) Хелаты марганца и их применение в качестве контрастных агентов в магнитно-резонансной визуализации (mpb)
JP2010505865A5 (enExample)
JP2012504131A5 (enExample)